Behavioral outcomes were assessed through the open field, three-chamber social interaction test and elevated plus maze, revealing improvements in repetitive behaviors, sociability, and anxiety-like response in vitamin E + VPA group (Alinaghi Langari et al., 2021)
Tranexamic Acid, Alpha Arbutin, Niacinamide, Vitamin C, Kojic Acid, Glutathione, and Retinoids
Reduce IGF-1 LR3 dose by 4050% and increase daily water intake to 1 gallon minimum
No evidence supports cycling versus continuous use, and no studies have determined optimal treatment duration
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165